Compositions and methods for treating cutaneous conditions

Abstract

A composition for treating cutaneous condition is provided and has 0.001-1.000 wt. % Aloe barbadensis Leaf Juice, 1.000-40.000 wt. % Cyclopentasiloxane and Dimethicone Crosspolymer, 0.50-15.000 wt. % Dimethicone, 1.00-10.000 wt. % Ethoxydiglycol, 0.100-5.000 wt. % Glycerin, Water and Centella asiatica Extract Mixture, 1.000-30.000 wt. % Glycerin, 0.500-5.000 wt. % Hydroxyethyl Acetate/Sodium Acryloyldimethy Taurate Copolymer, 0.600-1.100 wt. % Phenoxyyethanoland Ethylexylglycerin, 1-6.00 wt. fry PPG-12 SMDI Copolymer, 0.00100-0.1000 wt. % GMP Grade Recombinant Human TGF-B3, 0.010-0.3000 wt. % GMP Grade Recombinant Human IL10, 0.010-0.9000 wt. % GMP Grade Recombinant Human bFGF, 0.010-2.00 wt, % Sodium Hyaluronate, 0.1000-10.000 wt. % Tetrahexyldecyl Ascorbate, 30.000-80.000 wt % Water.

We claim: 
     
         1 . A composition for treating cutaneous condition which comprises 0.015-0.250 wt. %  Aloe Barbadensis  Leaf Juice, 5.000-15.000 wt. % Cyclopentasiloxane and Dimethicone Crosspolymer, 4.00-8.000 wt. % Dimethicone, 1.50-4.000 wt. % Ethoxydiglycol, 1.000-3.000 wt. % Glycerin, Water and  Centella asiatica  Extract Mixture, 12.000-25.000 wt. % Glycerin, 2.000-4.000 wt. % Hydroxyethyl Acetate/Sodium Acryloyldimethy Taurate Copolymer, 0.800-1.100 wt. % Phenoxyyethanol and Ethylexylglycerin, 1.500-4.00 wt. % PPG-12 SMDI Copolymer, 0.0010-0.1000 wt. % GMP Grade Recombinant Human TGF-B3, 0.010-0.3000 wt. % GMP Grade Recombinant Human IL10, 0.010-0.9000 wt. % GMP Grade Recombinant Human bFGF, 0.25-1.00 wt. % Sodium Hyaluronate, 1.000-3.000 wt. % Tetrahexyldecyl Ascorbate, and water to make 100% 
     
     
         2 . A composition for treating cutaneous conditions which comprises 0.001-1.000 wt. %  Aloe Barbadensis  Leaf Juice, 1.000-40.000 wt. % Cyclopentasiloxane and Dimethicone Crosspolymer, 0.50-15.000 wt. % Dimethicone, 1.00-10.000 wt. % Ethoxydiglycol, 0.100-5.000 wt. % Glycerin, Water and  Centella asiatica  Extract Mixture, 1.000-30.000 wt. % Glycerin, 0.500-5.000 wt. % Hydroxyethyl Acetate/Sodium Acryloyldimethy Taurate Copolymer, 0.600-1.100 wt. % Phenoxyyethanoland Ethylexylglycerin, 1-6.00 wt. % PPG-12 SMDI Copolymer, 0.00100-0.1000 wt. % GMP Grade Recombinant Human TGF-B3, 0.010-0.3000 wt. % GMP Grade Recombinant Human IL10, 0.010-0.9000 wt. % GMP Grade Recombinant Human bFGF, 0.010-2.00 wt. % Sodium Hyaluronate, 0.1000-10.000 wt. % Tetrahexyldecyl Ascorbate, and water to make 100%. 
     
     
         3 . A composition for treating cutaneous conditions which comprises 0.015-0.250 wt. %  Aloe Barbadensis  Leaf Juice, 5.000-15.000 wt. % Cyclopentasiloxane and Dimethicone Crosspolymer, 4.00-8.000 wt. % Dimethicone, 1.50-4.000 wt. % Ethoxydiglycol, 1.000-3.000 wt. % Glycerin, Water and  Centella asiatica  Extract Mixture, 12.000-25.000 wt. % Glycerin, 2.000-4.000 wt. % Hydroxyethyl Acetate/Sodium Acryloyldimethy Taurate Copolymer, 0.800-1.100 wt. % Phenoxyyethanol and Ethylexylglycerin, 1.500-4.00 wt. % PPG-12 SMDI Copolymer, 0.00100-0.1000 wt. % GMP Grade Recombinant Human TGF-B3, 0.010-0.3000 wt. % GMP Grade Recombinant Human IL10, 0.010-0.9000 wt. % GMP Grade Recombinant Human bFGF, 0.25-1.00 wt. % Sodium Hyaluronate, 1.000-3.000 wt. % Tetrahexyldecyl Ascorbate and water to make 100%.